27/10/2026
What if the fastest route to the US market isn't the one you initially planned?
For European MedTech companies looking to enter the US, commercialization involves more than regulatory filings. It requires connecting product strategy, regulatory pathways, partnerships and business objectives.
In our latest article, Blythe Karow of The Karow Advisory Group shares the story of StethoMe, a Polish MedTech company bringing its electronic stethoscope to the US market.
Through a real-world case study, Blythe explores how an unexpected regulatory opportunity helped the company identify a faster route to market, potentially bringing its first product to market in weeks rather than months.
Read the full article to find out.
π https://med-tech.world/news/wearable-faster-us-market-entry/
Join us for MedTech World Europe 2026
π
11-13 Nov 2026 | MCC, Valletta, Malta
ποΈSecure your pass: https://tickets.med-tech.world/medtechworld-malta-2026/
Discover how Blythe Karow helped StethoMe identify a faster path to the US market through strategic product planning & FDA regulatory pathways.